A novel "salting-out" procedure for the isolation of tumor-derived exosomes

Journal of Immunological Methods

Volumn 407, Issue , 2014, Pages 120-126

  Brownlee, Zachary ^a   Lynn, Kristi D ^a   Thorpe, Philip E ^a   Schroit, Alan J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Exosomes; Precipitation; Tissue culture; Tumors

Indexed keywords

ACETIC ACID; ALPHA 2 MACROGLOBULIN; LIPOCORTIN 5;

ARTICLE; CELL ISOLATION; CONTROLLED STUDY; EXOSOME; MASS SPECTROMETRY; MELANOMA CELL; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; PROTEIN ANALYSIS; SALTING OUT METHOD; SUPERNATANT; TISSUE CULTURE; TUMOR CELL; TUMOR CELL CULTURE; ULTRACENTRIFUGATION;

EXOSOMES; PRECIPITATION; TISSUE CULTURE; TUMORS;

ACETATES; ANIMALS; CELL LINE, TUMOR; CHEMICAL PRECIPITATION; CULTURE MEDIA, CONDITIONED; EXOSOMES; HUMANS; HYDROGEN-ION CONCENTRATION; MICE; NEOPLASMS; SALTS; SOLUBILITY; ULTRACENTRIFUGATION;

EID: 84901399595     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.04.003     Document Type: Article

References (34)

1. Aharon A., Brenner B. Microparticles, thrombosis and cancer. Best Pract. Res. Clin. Haematol. 2009, 22:61.
2. Al Nedawi K., et al. Mast cell-derived exosomes activate endothelial cells to secrete plasminogen activator inhibitor type 1. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1744.
3. Andre F., et al. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol. 2004, 172:2126.
4. Andreola G., et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J. Exp. Med. 2002, 195:1303.
5. Bizik J., et al. Human tumor cells synthesize and secrete alpha-2-macroglobulin in vitro. Int. J. Cancer 1986, 37:81.
6. Chaput N., et al. The potential of exosomes in immunotherapy. Expert. Opin. Biol. Ther. 2005, 5:737.
7. Cho J.A., et al. MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models. Cancer Lett. 2009, 275:256.
8. Clayton A., et al. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J. Immunol. Methods 2001, 247:163.
9. Dai S., et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol. Ther. 2008, 16:782.
10. Escudier B., et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J. Transl. Med. 2005, 3:10.
11. Grant R., et al. A filtration-based protocol to isolate human plasma membrane-derived vesicles and exosomes from blood plasma. J. Immunol. Methods 2011, 371:33-43.
12. Huber V., et al. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 2005, 128:1796.
13. Iero M., et al. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ. 2008, 15:80.
14. Keller S., et al. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett. 2009, 278:73.
15. Kim J.W., et al. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin. Cancer Res. 2005, 11:1010.
16. Logozzi M., et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One 2009, 4:e5219.
17. Marx G., et al. Heat denaturation of fibrinogen to develop a biomedical matrix. J. Biomed. Mater. Res. B Appl. Biomater. 2008, 84:49.
18. Millar H.R., et al. An evaluation of the heat precipitation method for plasma fibrinogen estimation. J. Clin. Pathol. 1971, 24:827.
19. Mitchell J.P., et al. Increased exosome production from tumour cell cultures using the Integra CELLine Culture System. J. Immunol. Methods 2008, 335:98.
20. Morgan A.C. alpha 2-Macroglobulin production by cultured human melanoma cells. J. Natl. Cancer Inst. 1984, 72:557.
21. Parolini I., et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J. Biol. Chem. 2009, 284:34211.
22. Rabinowits G., et al. Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cancer 2009, 10:42.
23. Skog J., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 2008, 10:1470.
24. Szajnik M., et al. Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS ONE 2010, 5:e11469.
25. Taylor D.D., Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 2008, 110:13.
26. Taylor D.D., et al. Exosome isolation for proteomic analyses and RNA profiling. Methods Mol. Biol. 2011, 728:235.
27. Thery C., et al. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2002, 2:569.
28. Thery C., et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. 2006, 3.22.1-3.22.29.
29. Thery C., et al. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 2009, 9:581.
30. Valenti R., et al. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res. 2007, 67:2912.
31. Wieckowski E.U., et al. Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J. Immunol. 2009, 183:3720.
32. www.biooscientific.com (US patent application 2013/0052647).
33. www.systembio.com/exoquick (US patent application 2013/0337440); (US patent application 2013/0273544). http://www.lifetechnologies.com.
34. Zwaal R.F., van Deenen L.L. Interactions between proteins and lipids from human red cell membranes. Chem. Phys. Lipids 1970, 4:311.